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We have developed genetically encoded fluorescent
sensors for reduced nicotinamide adenine dinucleo-
tide (NADH), which manifest a large change in fluo-
rescence upon NADH binding. We demonstrate the
utility of these sensors in mammalian cells by moni-
toring the dynamic changes in NADH levels in subcel-
lular organelles as affected by NADH transport,
glucose metabolism, electron transport chain func-
tion, and redox environment, and we demonstrate
the temporal separation of changes in mitochondrial
and cytosolic NADH levels with perturbation. These
results support the view that cytosolic NADH is
sensitive to environmental changes, while mitochon-
dria have a strong tendency tomaintain physiological
NADH homeostasis. These sensors provide a very
good alternative to existing techniques that measure
endogenous fluorescence of intracellular NAD(P)H
and, owing to their superior sensitivity and speci-
ficity, allow for the selective monitoring of total
cellular and compartmental responses of this essen-
tial cofactor.
INTRODUCTION
Reduced nicotinamide adenine dinucleotide (NADH) and its
oxidized form, NAD+, are the most important coenzymes found
in all living cells. They participate and play critical roles inmultiple
biological processes, including energy metabolism, mitochon-
drial function, biosynthesis, gene expression, calcium homeo-
stasis, cell death, aging, and carcinogenesis (Eto et al., 1999;
Kasischke et al., 2004; Lin and Guarente, 2003; Rutter et al.,
2001; Vemuri et al., 2007; Vlassenko et al., 2006; Zhang et al.,
2002, 2006). There are a few accepted methods for assaying
NADH in vitro, including capillary electrophoresis (Xie et al.,
2009), high-performance liquid chromatography (Yang et al.,Cell2007), and a conventional enzymatic cycling assay (Zhang
et al., 2002, 2006). To monitor intracellular NADH levels,
researchers have utilized methods and instrumentation for
imaging its weak endogenous fluorescence by single-photon
or dual-photon excitation (Kasischke et al., 2004; Patterson
et al., 2000; Skala et al., 2007); however, these methods have
the drawbacks of low sensitivity and cell injury resulting from
the ultraviolet irradiation. In addition, there is no way to distin-
guish between NADH and reduced nicotinamide adenine dinu-
cleotide phosphate (NADPH), as they have similar fluorescent
properties but distinct functions in cells.
Recently, investigators have developed genetically encoded
fluorescent biosensors by fusing sensitive protein domains
with circularly permuted fluorescent proteins (cpFPs) for moni-
toring various intracellular events (Belousov et al., 2006;
Berg et al., 2009; Nagai et al., 2004; Wang et al., 2008b). In
these cpFPs, the original amino and carboxyl termini are
fused by a polypeptide linker, and new termini are formed
close to the fluorophore, making its fluorescence highly sensi-
tive to the intramolecular microenvironment. In different organ-
isms from bacteria to mammals, cells developed transcription
factors that directly sense intracellular NADH concentrations
(McLaughlin et al., 2010; Rutter et al., 2001; Zhang et al.,
2002, 2006). Among them, the bacterial protein Rex is specifi-
cally sensitive to NADH. Crystallographic studies of the Rex
dimer showed that NADH binding induces a dramatic transition
from an open to a closed form (McLaughlin et al., 2010; Wang
et al., 2008a). To overcome the disadvantages of existing
methods, we have developed genetically encoded sensors for
monitoring intracellular NADH in living cells that exploit the
properties of these two proteins, cpFP and Rex. These sensors,
denoted Frex and FrexH, consist of circularly permuted yellow
fluorescent protein (cpYFP) inserted into a tandem dimer of
Bacillus subtilis Rex protein. The sensors demonstrate highly
specific affinity for NADH and do not respond to NADH
analogs, including NADPH. We demonstrate the utility of Frex
in mammalian cells on monitoring changes in NADH levels,
including changes in subcellular organelles, as affected by
NADH transport, glucose metabolism, electron transport, and
redox regulation.Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc. 555
Figure 1. Properties of the Genetically En-
coded NADH Sensor Frex
(A) Model for NADH sensing by the Rex homo-
dimer. NADH binding induces conformational
changes, which bring the N-terminal DNA binding
domains together.
(B) Design of Frex, which is a fusion of a complete
Rex monomer, cpYFP, and the NADH-binding
domain of a second Rex molecule. The fluores-
cence of cpYFP is highly sensitive to the confor-
mational changes induced by NADH.
(C) Fluorescence spectra of purified Frex. Excita-
tion spectrum recorded at an emission wavelength
of 530 nm has two maxima at 420 nm and 500 nm.
Emission spectrum recorded at an excitation
wavelength of 498 nm has a maximum at 518 nm.
(D) Fluorescence intensities with excitation at
410 nm or 500 nm normalized to the initial value;
emission at 528 nm. Error bars represent SEM.
(E) The ratio of fluorescence intensities with exci-
tation at 500 nm divided by 410 nm (F500 nm/
F410 nm) in the presence of different concentra-
tions of NADH and its analogs. Error bars repre-
sent SEM. See also Figure S1.
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Generation of cpYFP-Based Fluorescent Sensors
for NADH
In the present study, we first constructed three chimeras in which
cpYFP is insertedbetween twoBacillus subtilisRexsubunits (Fig-
ure S1A). All three fusion proteins expressed in E. coli were fluo-
rescent, while only one of them showed amarked change of fluo-
rescence in the presence of NADH. This sensor, NS2 (NADH
Sensor 2), is a fusion of a complete Rex monomer, cpYFP, and
the NADH-binding domain of Rex (Figures 1A and 1B). We found
that direct incubation of NADH with purified NS2 decreased its
fluorescence emission at 528 nm upon excitation at 485 nm
and increased its fluorescenceuponexcitation at 390nm, leading
to a 55% increase in the ratio of fluorescence emission intensity
with excitation at 390 nm and 485 nm (Figures S1B and S1C).
In order to maximize the magnitude of the response of NS2 fluo-
rescence to NADHbinding, we created a series of truncated vari-
ants, targeting residues involved in the linker between Rex and
cpYFP (Figure S1D). Two truncated variants had a dramatic
increase (C3) or decrease (C8) in fluorescence intensity when
excited at 485 nm in response to NADH (Figure S1D).
Native Rex proteins from B. subtilis have a high affinity for
NADH (24 nM), but also bind to NAD+ and NADPH (Wang
et al., 2008a), leading to the possibility that the sensors could
be saturated under physiological levels of NADH or be affected
by high concentrations of free NAD+ in the cell. To expand the
dynamic range of NADH sensing and to increase the selectivity
toward NADH versus its analogs NAD+ and NADPH, we
screened 20 variants of the sensors with single site-directed
mutagenesis of amino acid residues around the NADH binding
pocket (Wang et al., 2008a) (Figures S1E and S1F). Among all
of these encoded variants, C3L194E and C8N120E exhibited
a 9-fold increase and 3-fold decrease in fluorescence with exci-556 Cell Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Intation at 500 nm upon NADH binding, respectively (Figures 1D
and S1H), making them among the most responsive genetic
sensors available to date. These sensors have typical excitation
and emission spectra of the cpYFP-based genetically encoded
sensors, with two excitation peaks around 421 nm and 500 nm
and one emission peak at 518 nm (Figures 1C and S1G). Fluores-
cence titration studies showed that C3L194E had an apparent
Kd for NADH of 3.7 mM at pH 7.4, which increased to 11 mM
at pH 8.0 (Figures 1D, 1E, and S1K). The affinity of C8N120E
for NADH is too high to be measured by fluorescence titration,
and the Kd was determined to be 40 nM by Bio-Layer Interfer-
ometry (data not shown), which is close to wild-type Bacillus
subtilis Rex (Wang et al., 2008a). Both sensors are highly selec-
tive toward NADH, showing no apparent fluorescence changes
in the presence of NADH analogs, e.g., NAD+, NADPH, or
NADP+ (Figures 1E and S1I). As all other genetically encoded
sensors based on circular permuted fluorescent proteins (Belou-
sov et al., 2006; Berg et al., 2009; Nakai et al., 2001), the fluores-
cence of Frex is also sensitive to pH (Figure S1J.). Frex and
cpYFP have very similar pH responses. Thus, the effect of pH
on NADH determinants can be corrected when Frex fluores-
cence is normalized by cpYFP fluorescencemeasured in parallel
experiments (Figure S1J). Overall, these data show that
C3L194E and C8N120E are highly selective, highly responsive,
ratiometric genetically encoded sensors for NADH, and we
therefore termed them Frex (fluorescent Rex) and FrexH (Frex
of high affinity), respectively. These sensors were used for all
subsequent experiments, as their ratiometric properties provide
a great advantage for intracellular imaging and detection.
Subcellular Distribution and Transport of NADH
in Mammalian Cells
To test the ability of Frex to report changes in intracellular NADH
levels, we subcloned it into a mammalian expression vector andc.
Figure 2. Subcellular Distribution and
Transport of NADH in Mammalian Cells
(A) Ratiometric fluorescence images of cells
expressing Frex in mitochondria, nucleus, and
cytosol. The pixel-by-pixel ratios of the 488 nm
excitation image by the 405 nm excitation image of
the same cell were used to pseudocolor the
images. Scale bar, 10 mm.
(B) Normalized ratio of Frex and FrexH fluores-
cence excited at 500 nm to that at 410 nm in living
cells and measured in vitro with a fluorescence
plate reader in the presence or absence of 40 mM
or 10 mM NADH, respectively. Error bars represent
SEM.
(C and D) Fluorescence response of Frex with
excitation at 485 nm in 293FT cells treated with
exogenous NADH. Fluorescence was measured
immediately after NADH addition (C), or the fluo-
rescence intensity was followed over time (D). Error
bars represent SEM.
(E) Fluorescence response of Frex excited at
485 nm in digitonin-permeabilized cells. Error bars
represent SEM.
(F) Effects of P2X7R inhibitor PPADS on exoge-
nous NADH-induced fluorescence changes of
Frex in the cytosol. Error bars represent SEM.
(G) Ratiometric measurement of Frex-Mit or
C3L194K-Mit fluorescence by fluorescence
microscopy using a stable light source and
EMCCD. Error bars represent SD.
(H and I) Fluorescence response of Frex-Mit to
exogenous NADH in the absence of glucose.
Fluorescence was measured 60 min after NADH
addition (H), or the fluorescence intensity was fol-
lowed over time (I). Error bars represent SEM. All
experiments were performed in 293FT cells. Fluo-
rescence intensities were normalized to that of
resting cells (B–I). See also Figure S2.
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out the cell, excluding the nucleus, indicating cytosolic localiza-
tion (Figure 2A). When measured with a fluorescence plate
reader with dual excitation, the ratio of fluorescence intensities
with excitation at 500 nm divided by that at 410 nm was very
similar to that observed in purified, unliganded Frex (Figure 2B),
suggesting that cytosolic NADH concentration is extremely
low. However, when the high-affinity FrexH was expressed in
the cells, the ratio of fluorescence intensities suggested that
76% of FrexH proteins were occupied by NADH (Figure 2B),
reflecting a cytosolic NADH level of 0.13 mM.
Addition of exogenous NADH into the culture medium induced
an immediate, dose-dependent, and saturable increase of fluo-
rescence intensity with excitation at 485 nm in different cell lines,
which gradually returned to basal levels as the extracellularCell Metabolism 14, 555–56NADH was consumed, whereas addition
of much higher concentrations of NAD+
and NADPH had no effect on fluores-
cence (Figures 2C, 2D, S2B–S2D, and
S2H). The total NAD+:NADH pool in the
cells increased by about 25% when cells
were treated with (extracellular) NADH
(Figure S2I), whereas cellular NADHincreased 90% as measured by FACS. These data are consis-
tent with membrane transport of NADH. When the high-affinity
FrexH sensor was used instead, similar results were obtained,
suggesting NADH is readily transported across the plasma
membrane (Figure S2F). The results using Frex show that
NADH can be transported across the plasma membrane of cells
with an apparent Km in micromolar range (Figure 2C). In contrast,
in the cells expressing cpYFP instead of Frex, there were no fluo-
rescence changes when NADH was added to the cell culture
medium (Figure S2A), thereby excluding the possibilities of inter-
ference of fluorescence emission due to pH variations or redox
state of the cpYFP domain. Moreover, we found that Frex
displayed the same dramatic response to exogenous NADH in
digitonin-permeabilized cells as that of the purified protein
(Figure 2E). Digitonin permeabilization alone caused a slight6, October 5, 2011 ª2011 Elsevier Inc. 557
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which may due to leak of cytosolic NADH into the extracellular
environment. The level of cytosolic NADH was estimated to be
0.12 mM according to a digitonin permeabilization assay of
Frex-expressing cells(Figures 2E), which was very similar to the
results measured by the FrexH sensor. P2X7R is the only known
transporter that may be involved in NADH transport across the
plasma membrane (Lu et al., 2007); however, we found that the
P2X7R inhibitor PPADS did not affect the entry of NADH into
cells (Figure 2F), suggesting that some other mechanism is
involved in the high-affinity transport of NADH into the cells.
Collectively, these results indicate that Frex can distinguish
NADH from its analogs and displays superior specificity and
responsiveness in living cells.
We also tagged organelle-specific signal peptides to Frex to
direct its expression in the nucleus and mitochondria in order
to understand better the subcellular distribution of NADH in
mammalian cells (Figure 2A). The nuclear NADH level in resting
cells or cells treated with NADH and its analogs was similar to
that of cytosol (Figures 2A, S2A, and S2G), as NADH diffuses
freely between these two compartments. When targeted tomito-
chondria, however, the ratio of fluorescence intensities of Frex
with excitation at 500 nm to excitation at 410 nm was much
higher than untagged Frex localized in the cytosol. After carefully
calibrating the effect of pH on the fluorescence of Frex (Figures
2G, S1J, and S1K), we were able to quantify the free NADH level
in the mitochondria of living cells by ratiometric fluorescence
imaging of the Frex sensor (Figure 2G) and by comparing Frex-
Mit fluorescence in living cells to that of cell lysates in 0.3%
digitonin (pH 8.0) (Figure S2J). These results suggested that in
mitochondria of untreated 293FT cells, the Frex-Mit sensor
was 70%–75% (Figures 2G and S2J) saturated by NADH.
The free NADH level in the mitochondrial matrix was determined
to be 33 ± 9 mM and 26 ± 7 mM, respectively, by these
two methods. In contrast, a lower-affinity sensor, C3L194K
(Kd50 mM) (Figure S1K), was35% saturated in the mitochon-
drial matrix, suggesting a free NADH level in the mitochondrial
matrix of 27 ± 5 mM. As the binding sites of Frex-Mit were largely
occupied by NADH in mitochondria, its fluorescence remained
relatively constant when low concentrations of exogenous
NADH were added to cell culture (Figure S2E); however, in
energy-stressed cells in which glucose was removed from the
medium, exogenous NADH addition led to a marked yet slow
increase in mitochondrial NADH level (Figures 2H and 2I).
Inhibition of Respiratory Chain Complex II Oxidizes
Mitochondrial NADH
NADH is produced during glycolysis and via the tricarboxylic
acid (TCA) cycle. At the mitochondrial inner membrane, elec-
trons from NADH and succinate pass through the electron trans-
port chain to oxygen to drive the synthesis of ATP. By employing
different inhibitors, we next examined the role that different
mitochondrial complexes play in the metabolic balance of mito-
chondrial NADH:NAD+. It was surprising that the complex II
inhibitor, 3-NP, dose-dependently decreased mitochondrial
NADH levels, as indicated by the decrease of fluorescence inten-
sities of Frex-Mit with excitation at 485 nm (Figures 3A–3D
and S3A). The cells expressing cpYFP-Mit instead of Frex-Mit
showed no significant fluorescence changes during 3-NP treat-558 Cell Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inment (Figures 3C, 3D, and S3B). Other mitochondrial inhibitors
may induce pH variation in the mitochondrial matrix, which inter-
fere with the NADH measurement using a Frex sensor. In these
cases, we normalized Frex-Mit fluorescence with cpYFP-Mit
fluorescence measured in parallel experiments. The results
showed that the complex I, III, and IV inhibitors modestly
increased Frex-Mit fluorescence, consistent with the increase
of endogenous NADH fluorescence (Figures 3A, S3C, and
S3D). The oxygen consumption of 293FT cells was fully inhibited
by rotenone and other mitochondrial inhibitors (Figure S3E), sug-
gesting that these cells have a functional electron transport chain
and are respiring.
In many previous reports, rotenone as well as other mitochon-
drial inhibitors caused a marked increase of mitochondrial
NADH. The relatively small changes of fluorescence of Frex-
Mit induced by rotenone treatments is due to the fact that
majority of Frex sensor molecules are already bound with
NADH in the mitochondrial matrix of resting 293FT cells. The
increase of mitochondrial NADH induced by different complex
I, III, and IV inhibitors may be better visualized by a lower-affinity
sensor, C3L194K, whose fluorescence when excited at 488 nm
increasedmarkedly when cells were treated with these inhibitors
(Figure 3A). The complex I inhibitor, rotenone, essentially
reversed 3-NP-induced mitochondrial NADH oxidation (Fig-
ure 3B). We also performed a dual excitation calibration of the
Frex sensor in the mitochondria of transiently transfected cells
using fluorescence-activated cell sorting (FACS), which also
showed that the fluorescence intensity of Frex-Mit when
excited at 488 nm decreased in the presence of 3-NP, while
the fluorescence intensity of Frex-Mit when excited at 405 nm
remained unchanged, indicating mitochondrial NADH oxidation
(Figure 3E).
Consistent with the response of Frex fluorescence, the endog-
enous fluorescence of NAD(P)H measured by FACS using
a 375 nm laser showed a modest decrease of NAD(P)H levels
with different concentrations of 3-NP (Figure 3F). The mitochon-
drial uncoupler, carbonyl cyanide m-chlorophenylhydrazone
(CCCP), also dose-dependently decreased Frex-Mit fluores-
cence and NAD(P)H endogenous fluorescence, which was
largely reversed by the complex I inhibitor, rotenone (Figures
S3F and S3H). These results are consistent with previous reports
that mitochondrial NADH is oxidized during uncoupling electron
transport from ATP synthesis (Eng et al., 1989; Mayevsky, 1976).
CCCP also modestly decreased the fluorescence of cpYFP-Mit,
indicating a decrease of pH during mitochondrial uncoupling
(Figure S3G). Overall, these results show that Frex can be used
as a sensitive sensor to monitor mitochondrial NADH dynamics,
which is more specific than the conventional measurement of
endogenous fluorescence of NAD(P)H.
NADH Levels in Subcellular Compartments Depend
on Glucose, Pyruvate, and Lactate Transport
and the Malate-Aspartate Shuttle
Glucose metabolism is generally believed to increase intracel-
lular NADH levels (Eto et al., 1999; Patterson et al., 2000);
however, these reports relied on the endogenous fluorescence
assay that cannot distinguish between NADH and NADPH,
both of which are produced during glucose catabolism. By
measuring Frex and FrexH fluorescence in 293FT cells, we foundc.
Figure 3. Inhibition of Respiratory Chain Complex II Oxidizes Mitochondrial NADH
(A) Effect of different mitochondrial oxidative phosphorylation complex inhibitors on the fluorescence of Frex-Mit and C3L194K-Mit excited at 485 nm in 293FT
cells. Cells were treated with inhibitors for 30 min. Frex-Mit and C3L194K-Mit fluorescence were corrected for pH effect by normalization with cpYFP-Mit
fluorescence measured in parallel experiments. Error bars represent SEM.
(B) Respiratory chain complex II inhibitor 3-NP dose-dependently decreased Frex-Mit fluorescence, which is blocked by 5 mM complex I inhibitor rotenone.
Cells were treated with inhibitors for 30 min. Fluorescence intensities were normalized to that of untreated cells. Error bars represent SEM.
(C) Confocal fluorescence image of Frex-Mit- or cpYFP-Mit-expressing cells before and 10 min after treatment with 3-NP. Image was pseudocolored with the
ratio of the 488 nm excitation image to the 405 nm excitation images of the same cell. Scale bar, 10 mm.
(D) Kinetic course of averaged Frex-Mit and cpYFP-Mit ratio changes in the presence of 2 mM 3-NPmeasured by confocal microscopy. Error bars represent SD.
(E) FACS analysis fluorescence of 293FT cells expressing Frex-Mit in the absence of 3-NP (red) or in the presence of 3-NP (blue). Fluorescence was excited by
a 488 nm (upper) or 405 nm (lower) laser. A band-pass 530/30 emission filter was used in both cases.
(F) FACSmeasurements of endogenousNAD(P)H fluorescencewith excitation at 375 nmor Frex-Mit fluorescencewith excitation at 488 nm. Cells were incubated
with inhibitors for 30 min before measurements. See also Figure S3.
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Sensors for NADHthat cytosolic NADH levels slightly increase immediately upon
glucose supplementation in glucose-depleted cells (Figures 4C
and 4D). By contrast, under these same experimental conditions,
glucose had a marked effect on mitochondrial NADH levels.
Glucose dose-dependently increased Frex-Mit fluorescence,
whereas glucose also had a small yet slow effect on fluores-
cence in the cpYFP-Mit-expressing cells, suggesting a slightCellincrease of pH during the 1 hr time course (Figures 4A and 4B).
To correct the interference by pH change on NADH determina-
tions, we normalized Frex-Mit fluorescence by cpYFP-Mit fluo-
rescence measured in parallel experiments (Figures 4B). The
results suggested that the glucose-induced increase of Frex-
Mit fluorescence has a biphasic time course, e.g., a rapid phase
reflecting an NADH increase over 10 min and a slow phaseMetabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc. 559
Figure 4. Subcellular NADH Level Depends
on Glucose Transport
(A) Dose-dependent fluorescence response of
Frex-Mit and cpYFP-Mit to different concentra-
tions of glucose.
(B) Kinetics of fluorescence response of Frex-Mit
and cpYFP-Mit after glucose supplementation.
The solid symbol represents the fluorescence
response of Frex-Mit corrected for pH effects.
(C) Dose-dependent fluorescence response of
cytosolic Frex, FrexH, and cpYFP to different
concentration of glucose.
(D) Kinetics of fluorescence response of the
cytosolic FrexH and cpYFP in glucose-starved
cells after glucose supplementation. Error bars
represent SEM.
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Sensors for NADHreflecting a pH increase over 1 hr. Michaelis-Menten fitting of
mitochondria NADH level versus extracellular glucose concen-
tration gave a K0.5 of 0.16 mM, which is much lower than the
KM for GLUT1, the high-affinity glucose transporter in the plasma
membrane. By contrast, the K0.5 for cytosolic NADH level versus
extracellular glucose concentration is 1.5 mM (Figure 4C).
These results suggest that the NADH level in mitochondria is
very sensitive to low concentrations of glucose, with glucose
uptake not the rate-limiting step; by contrast, the cytosolic
NADH level responds to more physiologically and pathologically
relevant fluctuations of glucose levels in the range of 1–25 mM.
NADH generated by glycolysis may be transported into mito-
chondria and increase mitochondrial NADH level. Cytosolic
NADH lacks direct access to the mitochondria (McKenna et al.,
2006); however, it can enter the mitochondria via the malate-
aspartate shuttle. Aminooxyacetate (AOA) is a well-character-
ized inhibitor of the malate-aspartate shuttle (Eto et al., 1999).
We found that AOA dose-dependently decreased the fluores-
cence intensity of Frex-Mit using a microplate reader and
confocal microscopy (Figures 5A, 5C, S4A, and S4C), whereas
no significant change of Frex fluorescence was detected (Fig-
ure S4B). When cells were treated with the complex I inhibitor,
rotenone, however, AOA could no longer induce a decrease in
mitochondrial NADH. Furthermore, inhibition of the malate-
aspartate shuttle can be directly visualized by the Frex probe,
as AOA also significantly inhibited the increase in mitochondrial
NADH concentration when cells were treated with exogenous
NADH (Figures 5B). We also observed that AOA almost com-
pletely inhibited the glucose-induced increase in mitochondrial
free NADH (Figure 5D). By contrast, AOA decreased FrexH
fluorescence, suggesting an increase of cytosolic NADH level
in the cells (Figure S4D). These data suggest that the malate-
aspartate shuttle plays an important role in supplying NADH to
mitochondria in 293FT cells. In comparison, FACSmeasurement560 Cell Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc.failed to reveal significant changes in the
endogenous fluorescence of NAD(P)H in
living cells treated with AOA (Figure S4E).
In cytosol, it is generally believed that
pyruvate and lactate are in equilibrium
with cytosolic free NAD+ and NADH. It is
interesting that there were biphasic
responses of mitochondrial and cytosolicNADH levels to pyruvate, which is expected to shift the lactate
dehydrogenase equilibrium toward NAD+. Exogenous pyruvate
produced a rapid decrease in cytosolic NADH level, which then
returned to baseline in 30 min, as shown by the fluorescence
of FrexH sensors expressed in 293FT cells (Figures 6A and
S5A). In comparison, the mitochondrial NADH level first
decreased upon pyruvate addition, then recovered with over-
shooting during the 1 hr time course of the experiment (Fig-
ure 6B). This overshooting of NADH level may be explained by
subsequent pyruvate catabolism via the TCA cycle in mitochon-
dria. Compared to pyruvate, lactate induced a more rapid and
significant increase of mitochondrial NADH level in glucose-
starved cells, which was completely inhibited by AOA, the
malate-aspartate shuttle inhibitor (Figures 6D and 6F). The en-
hancing effect of lactate on mitochondrial NADH was, however,
absent in glucose-supplemented cells (Figure S5B). By contrast,
lactate readily elevated cytosolic NADH in both glucose-supple-
mented cells and glucose-starved cells (Figures 6C and 6E).
These data suggest that although pyruvate can enter the
mitochondria and is utilized, lactate is a more rapid source of
energy by delivering NADH to mitochondria via the malate-
aspartate shuttle, which is particularly important in energy-
stressed conditions.
Mitochondrial NADH Is Sensitive to Hydrogen Peroxide
Theelectron transport chain present inmitochondria has apotent
side effect: the constant generation of reactive oxygen species
(ROS), including O2
 and H2O2 (Balaban et al., 2005). To deter-
mine whether ROS regulate mitochondrial redox metabolism,
we analyzed the effects of H2O2 on intracellular NADH levels.
We observed a moderate decrease of endogenous NAD(P)H
fluorescence measured by FACS (Figure S6); however, it is
possible that the decrease of endogenous NAD(P)H fluores-
cence reflects the consumption of NADPH by antioxidant
Figure 5. Mitochondrial NADH Level
Decreased during Malate-Aspartate Shuttle
Inhibition
(A) Fluorescence response of Frex-Mit-expressing
cells excited at 485 nm in the presence of different
concentrations of the malate-aspartate shuttle
inhibitor AOA. Rotenone blocked the decrease of
mitochondrial NADH level induced by AOA. Cells
were treated with inhibitors for 20 min. Error bars
represent SEM.
(B) AOA blocked the entry of exogenous NADH
into mitochondria. Fluorescence responses of
glucose-starved, Frex-Mit-expressing cells ex-
cited at 485 nm were measured 60 min after
addition of 0.4 mM AOA. Error bars represent
SEM.
(C) Kinetic course of averaged Frex-Mit and Frex
ratio changes in the presence of 0.4 mM AOA,
measured by confocal microscopy. Error bars
represent SD.
(D) AOA blocked the glucose-dependent increase
of mitochondrial NADH. Frex-Mit fluorescence
excited at 485 nm was measured 30 min after
glucose supplementation. Error bars represent
SEM. See also Figure S4.
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by H2O2. To understand better mitochondrial NADH levels
under oxidative conditions, fluorescence measurements were
preformed in Frex-Mit-expressing cells using a microplate
reader, FACS, and confocal microscopy. We observed amarked
decline in mitochondrial NADH upon addition of H2O2 as
measured with Frex-Mit (Figures 7A–7D and S6); cpYFP-Mit
had only modest florescence changes with 200 mM H2O2 treat-
ment as assayed by confocal microscopy (Figures 7B and 7C).
The oxidation of mitochondrial NADH induced by H2O2 was
partially abolished by inhibition of complex I (Figures 7A and
S6A). These data suggest a role for H2O2 in the regulation of
mitochondrial NADH levels, in agreement with previous reports
(Avi-Dor et al., 1962).
DISCUSSION
In this study, we report that Frex is a genetically encoded NADH
sensor for living cell research. The high sensitivity and specificity
of Frex toward NADH is based on the properties of B-Rex, which
is a NADH-sensing transcription factor from Bacillus subtilis
(Wang et al., 2008a). We mutated this bacterially derived
NADH binding domain to expand its dynamic sensing range
and to avoid nonspecific interactions of the probe with other
related biochemical species in eukaryotic cells. As other genet-
ically encoded sensors, Frex has the advantages of sensitivity,
minimal perturbation, and targeting to subcellular organelles,
allowing dynamic measurements in single living cells and even
subcellular organelles.
Redox homeostasis plays a key role in the sustained metabo-
lism and growth of prokaryotic and eukaryotic cells, and free
NADH concentration is one of the most important redox para-
meters for normal cellular metabolism and signaling (Lin and
Guarente, 2003). Studies show, for example, that the intracellularCellconcentration of NADH is directly linked to carcinogenic poten-
tial, as cancer cells primarily use glycolysis for rapid growth and
proliferation (DeBerardinis et al., 2008; Vander Heiden et al.,
2009). In b cells of the pancreas, the NADH shuttle couples
glycolysis with activation of mitochondrial energy metabolism
to trigger insulin secretion (Eto et al., 1999). For many years,
investigators have been indirectly assuming static cytosolic
and mitochondria NADH concentrations according to the ratios
of NAD+/NADH of700–1000 in cytosol and 7–8 in mitochondria
(Stubbs et al., 1972; Williamson et al., 1967; Zhang et al., 2002).
These ratios were also indirectly obtained by combining in vitro
measurements of cell extracts and equilibrium considerations
of the lactate dehydrogenase and b-hydroxybutyrate dehydro-
genase systems; however, these estimations have been difficult
to verify with precision. To monitor NADH in living cells and
tissues, all current methods rely on the weak endogenous
fluorescence of NADH and its phosphorylated analog NADPH
(Kasimova et al., 2006; Zhang et al., 2002). These two coen-
zymes are regulated by different enzymatic pathways and have
distinct physiological roles; however, their fluorescence spectra
are indistinguishable.
In recent years, there have been a growing number of reports
on studies of free NADH that were largely focused on time-
resolved fluorescence (Blinova et al., 2005; Zhang et al., 2002),
fluorescence anisotropy (Vishwasrao et al., 2005; Yu and Heikal,
2009), and fluorescence spectral decomposition analysis
(Kasimova et al., 2006) measurements. The reported ratio of
free/bound mitochondrial NADH varies significantly from 1.5:1
(Blinova et al., 2005) to 1:4 (Yu and Heikal, 2009) or even 0:1
(Wakita et al., 1995). These apparent discrepancies may reflect
fundamental physiological differences between the role of free
NADH in themitochondria in their respective species and tissues
(Kasimova et al., 2006). These techniques require sophisticated
instrumentation and rigorous mathematical processing of theMetabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc. 561
Figure 6. Differential Response of Mito-
chondrial and Cytosolic NADH Level to
Pyruvate and Lactate Supplementation
(A–D) All experiments were performed in 293FT
cells. Fluorescence with excitation at 485 nm was
normalized to that of untreated cells. Shown are
time courses of fluorescence response of FrexH-
and cpYFP-expressing cells when 100 mM pyru-
vate (A) or 1 mM lactate (C) was added to the cell
culture medium in the absence of glucose and
time courses of fluorescence response of Frex-
Mit- and cpYFP-Mit-expressing cells when 1 mM
pyruvate (B) or 1 mM lactate (D) was added to the
cell culture medium in the absence of glucose.
(E) Dose-dependent response of cytosolic NADH
level to different concentration of lactate, as
measured by Frex and FrexH fluorescence.
(F) AOA blocked the lactate-induced increase
of mitochondrial NADH as measured by fluores-
cence of Frex-Mit 30 min after addition of lactate
to the cell culture medium in the absence of
glucose. Error bars represent SEM. See also
Figure S5.
Cell Metabolism
Sensors for NADHsignal, and their utility and data interpretation in biological
studies still need to be validated. An additional problem of note
is that it is not possible to calibrate absolute mitochondrial
NADH concentrations for comparison between different cells
by measuring NAD(P)H fluorescence (Mayevsky and Rogatsky,
2007). The cytosolic NADH level is extremely low (Bu¨cher
et al., 1972; Stubbs et al., 1972; Williamson et al., 1967), and
most of it is bound to protein (Bu¨cher et al., 1972; Zhang et al.,
2002). Even more important, its fluorescence signal is over-
whelmed by that of its analog, NADPH. Thus, there is currently
no method available to measure cytosolic NADH level in living
cells. In contrast, Frex fluorescence is much more sensitive
and specific for free NADH determination in cytosol, excluding
interference from its biochemical analogs, e.g., NAD+, NADPH,
and NADP+. Here, by monitoring Frex fluorescence, we were
able to quantify NADH levels spatiotemporally in different
subcellular organelles. Consistent with many reprints, mitochon-
drial free NADH concentrations are much higher than those of
the cytosol and nucleus.
It had generally been thought that NADH cannot be trans-
ported across the cell plasma membrane. For example, recent
work showed that NADH transport across the plasma mem-562 Cell Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc.brane of HEK293 cells was not observ-
able when measured using traditional
methods, with a small increase in signal
detected only when P2X7R protein was
overexpressed and high concentrations
of exogenous NADH were added to the
medium (Lu et al., 2007). It is surprising
that we were able to trace the transport
of exogenous NADH across the plasma
membrane readily in different cell lines
using Frex as a probe, measuring NADH
fluorescence, and by enzymatic cycling
assay. Furthermore, we found the inhib-
itor of P2X7R is not able to inhibit trans-port of NADH across the plasma membrane, suggesting that
some other mechanism is involved in the high-affinity transport
of NADH into cells. Although these data suggest membrane
transport of NADH, there remains the possibility that the NADH
is also facilitating cytosol reduction via reducing equivalent
transport across the plasma membrane. Further research is
necessary to address this issue.
NADHplays a central role inmitochondrial respiration.We now
show by Frex sensor that blocking the malate-aspartate shuttle
or complex II leads to a decrease in mitochondrial NADH level,
while complex I, III, and IV inhibitors increase mitochondrial
NADH level. We also observed that under glucose-starved con-
ditions, NADH, glucose, pyruvate, and lactate supplementation
significantly increase mitochondrial free NADH; however, these
effects were diminished when physiologically relevant concen-
trations of glucose were present. In comparison, cytosol NADH
levels respond to the above conditions in both energy-stressed
and unstressed cells. In addition, we also observed temporal
separation of mitochondrial NADH and cytosolic NADH levels
in different metabolic conditions. Exogenous NADH leads to
an immediate increase in cytosolic and nuclear NADH levels,
whereas transport of exogenous NADH into mitochondria
Figure 7. Mitochondrial NADH Level Is Sensitive to Hydrogen Peroxide
(A) Frex-Mit-expressing cells excited at 485 nm in the presence of different concentrations of H2O2. Five micromolar rotenone partially blocked the decrease of
Frex fluorescence. Cells were treated with H2O2 and rotenone for 10 min. Error bars represent SEM.
(B) Spatially resolved changes in the ratiometric fluorescence of Frex-Mit or cpYFP-Mit in sequential frames (left to right, 1 min per frame) in response to 200 mM
H2O2. Ratios of the 488 nm excitation by the 405 nm excitation of the same pixel were used to pseudocolor the images. Scale bar, 10 mm.
(C) Kinetic course of averaged Frex-Mit and cpYFP-Mit ratio changes across the cells measured by confocal microscopy. Error bars represent SD.
(D) FACS analysis of Frex-Mit fluorescence of cells untreated (red) or treated with 200 mMH2O2 for 30min (blue), with fluorescence excitation at 488 nmor 405 nm.
See also Figure S6.
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studies of inhibition of either the malate-aspartate shuttle or
complex II and of glucose, pyruvate, or lactate supplementation,
changes in mitochondrial NADH concentration took place after
more than 5 min, while fluctuation of the NADH level in the
cytosol occurred almost immediately. A temporal separation of
the NAD(P)H response toward glucose was also observed in
islet b cells, in which the mitochondrial signal was noticeably
delayed (Patterson et al., 2000). Taken together, these results
suggest that NADH concentration in the cytosol is sensitive
to environmental changes, while mitochondria have a strong
tendency to maintain physiological NADH homeostasis.
It should be noted that Frex sensors also have their own limi-
tations. First, Frex is sensitive to pH; therefore, one should
exercise caution under conditions that alter intracellular pH.
The effect of changes in pH were not marked when the probes
were expressed in the cytosol; however, when the probes
were expressed in mitochondria where a wider range of pH vari-
ation may occur depending on the metabolic status, the Frex
fluorescence signal should be corrected by cpYFP fluorescence
measured in parallel experiments, by pH-sensitive dyes, or by
red fluorescent proteins (Berg et al., 2009; Tantama et al.,
2011). It is also possible to generate a dual-function, genetically
encoded sensor by fusing the Frex sensor and the pH-sensitiveCellred fluorescent protein (Tantama et al., 2011), which can be used
to monitor free NADH and pH simultaneously. Second, Frex
sensors will not permit the measurement of the NADH:NAD+
ratio. The NAD+ and NADH pools of cytosol and mitochondria
are well separated. In the timescale of this study, it is unlikely
that either of these pools changed. Therefore, we believe that
the NADH:NAD+ ratio purely depends on the level of NADH.
Ideally, of course, a sensor for NADH:NAD+ is desirable, which
would be used much like the sensor for ATP/ADP (Berg et al.,
2009). It may be used together with Frex probes to measure all
three critical parameters, i.e., NADH, NAD+, and their ratio,
simultaneously in the cells. We have mutants of Frex that can
also bind and respond to NAD+; however, the magnitude of
responses toward NAD+ is similar to that of NADH. Therefore,
these mutants do not currently meet the requirements for
measuring the NADH:NAD+ ratio. We are currently developing
genetically encoded sensors for NADH:NAD+ ratio detection
of appropriate characteristics. Once obtained, these sensors
may be used together with Frex probes, making it possible to
measure NADH, NAD+, and their ratios simultaneously in the
cells.
Our results show that Frex is a powerful tool for investigating
the effect of various stimuli on NADH in living cells. We believe
that Frex provides a very good alternative to the measurementMetabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Inc. 563
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Sensors for NADHof the endogenous fluorescence of intracellular NAD(P)H, as it
is highly specific, has a large change in fluorescence upon
NADH binding, and can be targeted to different subcellular
compartments. These properties make Frex compatible with
high-throughput screening using microplate readers and flow
cytometers. The ability to image cytosolic and nuclear NADH
levels directly in real time could be very useful for better under-
standing of cellular signaling involving NADH, as many signal
transduction and transcription regulation events involve NADH
(Mintun et al., 2004; Rutter et al., 2001; Zhang et al., 2002,
2006). In addition to its use in basic research of multiple biolog-
ical processes in which NADH plays a central role, Frex also has
the potential to be used in drug discovery, asmany enzymes that
make and use NAD+ and NADH are important in pharmacology
and disease pathobiology (Khan et al., 2007; Sauve, 2008).
EXPERIMENTAL PROCEDURES
Characterization of Frex In Vitro
We stored the purified protein at 20C until experiments. Before experi-
ments, we placed aliquots of purified sensor protein into a cuvette containing
100 mM phosphate-buffered saline (KPi buffer, pH 7.4). Fluorescence was
measured using a Cary Eclipse spectrofluorimeter (Varian). After recording
the initial fluorescence, we added various nucleotides into the reaction solution
and recorded the spectrum immediately. For all excitation experiments, exci-
tation and emission slits were set to 5 nm. Excitation spectra were recorded
with an excitation range from 300 nm to 515 nm and an emission wavelength
of 530 nm. Readings were taken every 1 nmwith an integration time of 1 s, and
the photomultiplier tube (PMT) voltage was set at 800 V. For emission spectra,
the emission range was 510–600 nm, while the excitation wavelength was
498 nm. Other parameters were set as for excitation spectra. For nucleotide
titration, the protein was diluted in 100mMKPi buffer (pH 7.4) to a final concen-
tration of 0.5 mM. The fluorescence value of Frex, in the absence of nucleo-
tides, was measured by a Synergy Mx Monochromator-Based Multi-Mode
microplate reader with 410 nm and 500 nm excitation and 528 nm emission
or a filter-based Synergy 2 Multi-Mode microplate reader using 390 BP
10 nm (or 420 BP 10 nm), 485 BP 20 nm excitation, and 528 BP 20 nm emission
band-pass filters (BioTek). The stock solution of nucleotides was also
prepared in 100 mM KPi buffer (pH 7.4). Each assay was performed with
75 ml nucleotides and 75 ml protein in 96-well glass-bottom microplates (GE).
Fluorescence intensity was measured immediately.
Cell Culture
293FT cells (Invitrogen) were maintained in DMEM (high glucose) supple-
mented with 10% FBS (Bovogen, Melbourne, Australia), 0.1 mM MEM nones-
sential amino acids, 6 mM L-glutamine, and 1 mM sodium pyruvate at 37C in
a humidified atmosphere of 95% air and 5% CO2. COS-7 and HEK293 cells
were grown in DMEM with 10% FBS. Cells were plated in antibiotic-free
high-glucose DMEM supplemented with 10% FBS 16 hr before transfection.
We typically used 0.8 mg plasmids with 3.2 ml Lipofectamine 2000 for each
well of a 12-well plate according to the manufacturer’s protocol.
Fluorescence Microscopy
For confocal fluorescence microscopy, cells were plated on a 35 mm glass-
bottom dish with phenol red-free fresh growth medium and observed
24–30 hr posttransfection. Frex was expressed in different subcellular com-
partments by tagging with organelle-specific signal peptides. Images were
acquired using the Zeiss 710 laser scanning confocal microscopy (LSCM)
system on a Zeiss Axio Observer Z1 inverted microscope. A Plan Apo 63 3
1.4 NA oil immersion objective was utilized. Cells were maintained at 37C in
a humidified atmosphere using a CO2 incubator (PeCon). We excited the
biosensor sequentially line by line with the 405 nm (1.2% laser power) and
488 nm (2.6% laser power) laser line and with emission detection set to
500–550 nm. Scanning was performed using the ‘‘line mode,’’ 1024 3 1024
format, 12 bit depth, 23 line average, and 3.0 pinhole. Raw data were exported564 Cell Metabolism 14, 555–566, October 5, 2011 ª2011 Elsevier Into ImageJ software as 12 bit TIF for analysis. The pixel-by-pixel ratio of the
488 nm excitation image by the 405 nm excitation image of the same cell
was used to pseudocolor the images in HSB color space. Simply, the RGB
value (255, 0, 255) represents the lowest ratio, and the red (255, 0, 0)
represents the highest ratio, while the color brightness is proportional to the
fluorescent signals in both channels. To assess the Frex and C3L194K
sensor occupancy by NADH in mitochondria, we performed ratiometric fluo-
rescence imaging of living cells and purified recombinant sensor proteins
with or without NADH using a high-performance fluorescent microscopy
system equipped with Nikon Eclipse Ti-E automatic microscope, Photomet-
rics Evolve 512 EMCCD, and the highly stable Sutter Lambda XL light source.
A Plan Apo VC 60 3 1.2 NA water immersion objective was utilized. For dual-
excitation ratio imaging, 410 BP 20 nm, 480 BP 30 nm band-pass excitation
filters and 535/40 emission filter altered by a Lambda 10-XL filter wheel
(Shutter Instruments) were used. Images were captured using 512 3 512
format, 16 bit depth, and 100 ms exposure for both channels. For calibration,
Frex and C3L194K protein were diluted into 100 mM KPi buffer with 0.1%
bovine serum albumin (pH 8.0) to final concentrations of 0.1 mM and 0.3 mM,
respectively.
Live-Cell Fluorescence Measurement Using Microplate Reader
293FT cells were harvested by trypsinization and counted by hemocytometer
24–48 hr after transfection. Cells were washed and suspended in PBS
(HyClone), and aliquots of cells were incubated at 37C with different drugs
during the measurement. Fluorescence excited at 485 nm was measured
by a Synergy 2 Multi-Mode Microplate Reader with excitation filter 485 BP
20 nm and emission filter 528 BP 20 nm. Dual-excitation ratios were obtained
by a Synergy MX Multi-Mode Microplate Reader (BioTek) with 410 nm and
500 nm excitation and 528 nm emission for both excitation wavelengths. Fluo-
rescence values were background corrected by subtracting the intensity of
293FT cell samples not expressing Frex. Unless otherwise indicated, 25 mM
glucose was maintained in the buffer. Under our experimental conditions,
the main contribution to background autofluorescence originated from the
glass-bottom microplate rather than from cells.
Calibration of Intracellular NADH Levels
Intracellular NADH levels can be measured after calibration of Frex fluores-
cence in live cells with that of recombinant Frex protein. Ratiometric measure-
ment of Frex fluorescence is possible for Frex expressed in cytosol or nucleus;
however, it was difficult to measure accurately the weak fluorescence signal of
410 nm excitation of Frex sensor expressed in mitochondria by the microplate
reader. There is some overlap of the 410 nm excitation with mitochondrial FAD
autofluorescence, which may interfere with the assay. In these experiments,
samples containing equal numbers of Frex-expressing cells or untransfected
(control) cells were both measured. The background values (samples of
control cells) were subtracted from that of samples of Frex-expressing cells.
This correction basically eliminated the interference of not only the autofluor-
escence of the microplate, but also the autofluorescence of the cells. Themain
contributor of the overall background fluorescence when excited at 410 nm or
500 nm is that arising from the plate itself, as the sample buffer has readings
similar to those of samples with untransfected cells. Generally, cell autofluor-
escence with excitation at 500 nm is less than 2% of Frex or Frex-Mit fluores-
cence, and autofluorescence with excitation at 410 nm is less than 4% of Frex
fluorescence. There are no significant changes in cell autofluorescence
excited at 410 nm or 500 nm under different metabolic conditions. Therefore,
the effect of cell autofluorescence is negligible under these experimental
conditions. In contrast, cell autofluorescence is 12% ± 20% of Frex-Mit fluo-
rescence with excitation at 410 nm, which is more significant. The autofluores-
cence of these cells must be determined and used to correct the Frex-Mit
fluorescence with excitation at 410 nm. The main contributor to the measure-
ment error is the noise of the microplate reader. Therefore, the ratio of Frex-Mit
dual excitation should be measured by other means, e.g., microscopy using
a stable light source and high-performance EMCCD camera. For digitonin
permeabilization assay, Frex-Mit-expressing cells were resuspended with
PBS and lysed with 100 mM KPi buffer (pH 8.0) containing 0.3% digitonin;
Frex-expressing cells were resuspended with PBS buffer (pH 7.4) containing
0.001% digitonin. The fluorescence (excited at 485 nm) of cells or cell lysates
in the presence or absence of 100 mM NADH was then measured.c.
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NAD+ levels were measured by the enzymatic cycling assay according to
a previously described method (Szabo´ et al., 1996; Ying et al., 2001). NAD+
levels were assessed based on the reduction of MTT to formazan through
the intermediation of phenazine methosulfate. Cells were treated with different
concentrations of NADH at 37C for 2 min and then extracted and assayed.
Oxygen Consumption
Oxygen consumption was determined using the BD Oxygen Biosensor
System (BD Biosciences) as described previously (Wilson-Fritch et al.,
2004). We added 13 106 of 293FT cells to each well of BD Oxygen Biosensor
plate. Levels of oxygen consumption were measured under baseline condi-
tions and in the presence of NADH or mitochondrial inhibitors. Fluorescence
was recorded at 1 min intervals for 40 min by a Synergy 2 Multi-Mode Micro-
plate Reader (BioTek) with excitation filter 485 BP 20 nm and emission filter
645 BP 40 nm at 37C.
Statistical Analysis
Data are presented either as a representative example of a single experiment
repeated at least in triplicate or as three or more experiments. Data obtained
are represented as means ± SD or means ± SEM.
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